Eli Lilly & Biogen's Alzheimer's drugs may offer minimal impact despite aggressive marketing. Click here to get insights on ...

Ever since Biogen and Eisai’s Aduhelm (aducanemab) was approved in 2021 as the first antibody to treat Alzheimer’s disease by ...

Catalyst Pharmaceuticals CPRX reported adjusted earnings of 68 cents per share for the second quarter of 2025, beating the Zacks Consensus Estimate of 58 cents. The company had recorded adjusted ...

New evidence of effectiveness is cause to drop a Biden restriction on Medicare coverage for anti-amyloid treatments.

Detailed price information for Denali Therapeutics Inc (DNLI-Q) from The Globe and Mail including charting and trades.

Why does the brain of some people stay sharp into their 80s and beyond? An expert explains what 25 years of exploring the ...

The risk for several adverse health outcomes, including PTSD, traumatic brain injury and anxiety, was heightened among active ...

Loved ones, caregivers and supporters of Coloradans living with Alzheimer’s disease will join together Saturday, Aug. 23, for ...